- Induction of hypoxia-inducible factor-1alpha inhibits drug-induced apoptosis in the human leukemic cell line HL-60
-
Yook YJ, Seo YJ, Kang HJ, Ko SH, Shin HY, Lee JJ, Jeong G, Ahn HS
- KMID: 2252055
- Korean J Hematol.
- 2010 Sep;45(3):158-163.
- doi: 10.5045/kjh.2010.45.3.158
BACKGROUND: Leukemic cells originate from hypoxic bone marrow, which protects them from anti-cancer drugs. Although many factors that cause drug resistance in leukemic cells have been studied, the effect of... -
- CITED
-
- Close
- SHARE
-
- Close
- Differential Expression of PKD2-Associated Genes in Autosomal Dominant Polycystic Kidney Disease
-
Yook YJ, Woo YM, Yang MH, Ko JY, Kim BH, Lee EJ, Chang ES, Lee MJ, Lee S, Park JH
- KMID: 2053280
- Genomics Inform.
- 2012 Mar;10(1):16-22.
- doi: 10.5808/GI.2012.10.1.16
Autosomal dominant polycystic kidney disease (ADPKD) is characterized by formation of multiple fluid-filled cysts that expand over time and destroy renal architecture. The proteins encoded by the PKD1 and PKD2... -
- CITED
-
- Close
- SHARE
-
- Close
- A study of the relationship between clinical phenotypes and plasma iduronate-2-sulfatase enzyme activities in Hunter syndrome patients
-
Lee OJ, Kim SJ, Sohn YB, Park HD, Lee SY, Kim CH, Ko AR, Yook YJ, Lee SJ, Park SW, Kim SH, Cho SY, Kwon EK, Han SJ, Jin DK
- KMID: 2284314
- Korean J Pediatr.
- 2012 Mar;55(3):88-92.
- doi: 10.3345/kjp.2012.55.3.88
PURPOSE: Mucopolysaccharidosis type II (MPS II or Hunter syndrome) is a rare lysosomal storage disorder caused by iduronate-2-sulfatase (IDS) deficiency. MPS II causes a wide phenotypic spectrum of symptoms ranging... -
- CITED
-
- Close
- SHARE
-
- Close
